comparemela.com

Latest Breaking News On - Susanne embleton - Page 5 : comparemela.com

Pharming Group reports financial results for the first quarter of 2021

Pharming Group reports financial results for the first quarter of 2021 Results impacted by effects of COVID-19 in the US; recovery towards the end of Q1 2021 with expected return to growth in Q2 2021 LEIDEN, Netherlands, May 13, 2021 /PRNewswire/ Pharming Group N.V. ( Pharming or the Company ) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) presents its (unaudited) financial report for the first quarter of the year ended 31 March 2021. As previously announced, as of 1 January 2021, Pharming changed its presentation currency from Euro to US Dollars. The Company will hold an analyst conference call at 13.30 CET/07.30 EST today. Dial in details can be found on page 6 of this report

Pharming Group announces the filing of its 2020 Annual Report on Form 20-F with the U S Securities and Exchange Commission

(1) LEIDEN, Netherlands, April 7, 2021 /PRNewswire/ Pharming Group N.V. ( Pharming or the Company ) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces the filing of its Annual Report on Form 20-F for the year ended 31 December 2020 with the U.S. Securities and Exchange Commission (SEC), which is available on the Company s website www.pharming.com under Investors/SEC filings. About Pharming Group N.V. Pharming Group N.V. is a global, commercial stage biopharmaceutical company developing innovative protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs. The flagship of our portfolio is our recombinant human C1 esterase inhibitor (rhC1INH) franchise. C1INH is a naturally occurring protein that down regulates the complement cascade in order to control inflammation in affected tissues.

Pharming Group announces the publication of its 2020 Annual Report and convenes its 2021 AGM

Pharming Group announces the publication of its 2020 Annual Report and convenes its 2021 AGM LEIDEN, The Netherlands, April 6, 2021 /PRNewswire/ Pharming Group N.V. ( Pharming or the Company ) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces the publication of its Annual Report for the year ended 31 December 2020, which is available on the Company s website www.pharming.com under Investors/Financial Documents. In addition, the Company s 2021 Annual General Meeting (AGM) will be held at 16:00CET on Wednesday, 19 May 2021. The Notice to Convene, Explanatory Notes, meeting documents and Form of Proxy can be found on the Company s website, www.pharming.com under Investors/Shareholders Meetings.

Pharming Group announces the intention to nominate three Non-Executive Directors to the Board of Directors

Pharming Group announces the intention to nominate three Non-Executive Directors to the Board of Directors
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.